MedPath

Dry Eye Under China's Dynamic COVID-zero Strategy

Completed
Conditions
Dry Eye Symptoms
Registration Number
NCT05476068
Lead Sponsor
Yifeng Yu
Brief Summary

To compare the prevalence of dry eye symptoms and to investigate the association of the risk factors with the dry eye symptomatology among university students in the epidemic and non-epidemic areas of China under the COVID-zero strategy.

Detailed Description

As the COVID-19 outbreak at the end of 2019 spread around the world, the World Health Organization declared it a public health emergency of international concern on 30th January, and a global pandemic on 1st March. In addition to the threat of coronavirus itself, anti-epidemic measures such as wearing masks, maintaining social distance, prohibiting group gathering, blockade, isolation, curfew, closure, working at home, online learning, etc., have also greatly changed people's daily life dynamics. Unlike the previous regional blockade (city-wide) suspension of school and work, China has shifted to dynamic prevention and control in April 2020, and the basic life and activities in the epidemic area are not restricted. This study aims to compare the prevalence of dry eye symptoms and to investigate the association of the risk factors with dry eye symptoms among college students in the epidemic and non-epidemic areas of China under the dynamic COVID-zero strategy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1807
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A score of PHQ-9 questionnaireDAY 0

PHQ-9 questionnaire: (1) 0 \< PHQ-9 ≤ 4 (normal), 5 ≤ GAD-7 ≤ 9 (mild depression), 10 ≤ GAD-7 ≤ 14 (moderate depression), 15 ≤ GAD-7 ≤ 19 (moderate and severe depression), and 20 ≤ GAD-7 ≤ 27 (severe depression).

A score of ocular surface disease index (OSDI)questionnaireDAY 0

Ocular surface disease index (OSDI)questionnaire : (1) OSDI: ≤12 (no DED symptoms), 13 ≤ d ≤ 22 (mild DED symptoms), 23 ≤ d ≤ 32 (moderate DED symptoms), and ≥33 (severe DED symptoms).

A score of GAD-7 questionnaireDAY 0

GAD-7 questionnaire: (1) 0 \< GAD-7 ≤ 4 (normal), 5 ≤ GAD-7 ≤ 9 (mild anxiety), 10 ≤ GAD-7 ≤ 13 (moderate anxiety), 14 ≤ GAD-7 ≤ 18 (moderate and severe anxiety), and 19 ≤ GAD-7 ≤ 21 (severe anxiety).

Secondary Outcome Measures
NameTimeMethod
Students' increased use of mobile phonesDAY 0

Students choose to increase the time of using mobile phones according to options: 0 hours, less than 1 hour, 1-3 hours, 3-5 hours, 5-7 hours, and more than 7 hours

Frequency of student sportsDAY 0

Students choose the frequency of sports according to the options, which are: less than once a month, 2-3 times a month, 1-2 times a week, 3-5 times a week, and once a day.

A score of UCLA Loneliness Scale questionnaireDAY 0

UCLA Loneliness Scale Questionnaire: (1) UCLA \< 28 (low loneliness), 28 ≤ UCLA ≤ 33 (generally lower), 33 \< UCLA ≤ 39 (intermediate level), 39 \< UCLA ≤ 44 (generally higher), and GAD-7 \> 44 (highly lonely).

Trial Locations

Locations (1)

The Second Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, Jiangxi, China

© Copyright 2025. All Rights Reserved by MedPath